359 related articles for article (PubMed ID: 17030807)
1. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition.
Chiu YL; Witkowska HE; Hall SC; Santiago M; Soros VB; Esnault C; Heidmann T; Greene WC
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15588-93. PubMed ID: 17030807
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3G: an intracellular centurion.
Chiu YL; Greene WC
Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):689-703. PubMed ID: 19008196
[TBL] [Abstract][Full Text] [Related]
3. Biochemical fractionation and purification of high-molecular-mass APOBEC3G complexes.
Chiu YL
Methods Mol Biol; 2011; 718():185-206. PubMed ID: 21370050
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of Alu retrotransposition by APOBEC3G.
Hulme AE; Bogerd HP; Cullen BR; Moran JV
Gene; 2007 Apr; 390(1-2):199-205. PubMed ID: 17079095
[TBL] [Abstract][Full Text] [Related]
5. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules.
Gallois-Montbrun S; Kramer B; Swanson CM; Byers H; Lynham S; Ward M; Malim MH
J Virol; 2007 Mar; 81(5):2165-78. PubMed ID: 17166910
[TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells.
Stopak KS; Chiu YL; Kropp J; Grant RM; Greene WC
J Biol Chem; 2007 Feb; 282(6):3539-46. PubMed ID: 17110377
[TBL] [Abstract][Full Text] [Related]
7. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
Chiu YL; Soros VB; Kreisberg JF; Stopak K; Yonemoto W; Greene WC
Nature; 2005 May; 435(7038):108-14. PubMed ID: 15829920
[TBL] [Abstract][Full Text] [Related]
8. The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules.
Kozak SL; Marin M; Rose KM; Bystrom C; Kabat D
J Biol Chem; 2006 Sep; 281(39):29105-19. PubMed ID: 16887808
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F.
Khatua AK; Taylor HE; Hildreth JE; Popik W
Virology; 2010 Apr; 400(1):68-75. PubMed ID: 20153011
[TBL] [Abstract][Full Text] [Related]
10. Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H.
Soros VB; Yonemoto W; Greene WC
PLoS Pathog; 2007 Feb; 3(2):e15. PubMed ID: 17291161
[TBL] [Abstract][Full Text] [Related]
11. Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunits.
Wedekind JE; Gillilan R; Janda A; Krucinska J; Salter JD; Bennett RP; Raina J; Smith HC
J Biol Chem; 2006 Dec; 281(50):38122-6. PubMed ID: 17079235
[TBL] [Abstract][Full Text] [Related]
12. Direct evidence that RNA inhibits APOBEC3G ssDNA cytidine deaminase activity.
McDougall WM; Smith HC
Biochem Biophys Res Commun; 2011 Sep; 412(4):612-7. PubMed ID: 21856286
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins.
Gallois-Montbrun S; Holmes RK; Swanson CM; Fernández-Ocaña M; Byers HL; Ward MA; Malim MH
J Virol; 2008 Jun; 82(11):5636-42. PubMed ID: 18367521
[TBL] [Abstract][Full Text] [Related]
14. Characterization of APOBEC3G binding to 7SL RNA.
Bach D; Peddi S; Mangeat B; Lakkaraju A; Strub K; Trono D
Retrovirology; 2008 Jul; 5():54. PubMed ID: 18597676
[TBL] [Abstract][Full Text] [Related]
15. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation.
Kreisberg JF; Yonemoto W; Greene WC
J Exp Med; 2006 Apr; 203(4):865-70. PubMed ID: 16606671
[TBL] [Abstract][Full Text] [Related]
16. DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315.
Polevoda B; Joseph R; Friedman AE; Bennett RP; Greiner R; De Zoysa T; Stewart RA; Smith HC
J Biol Chem; 2017 May; 292(21):8642-8656. PubMed ID: 28381554
[TBL] [Abstract][Full Text] [Related]
17. Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G.
Rose KM; Marin M; Kozak SL; Kabat D
AIDS Res Hum Retroviruses; 2005 Jul; 21(7):611-9. PubMed ID: 16060832
[TBL] [Abstract][Full Text] [Related]
18. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.
Pion M; Granelli-Piperno A; Mangeat B; Stalder R; Correa R; Steinman RM; Piguet V
J Exp Med; 2006 Dec; 203(13):2887-93. PubMed ID: 17145955
[TBL] [Abstract][Full Text] [Related]
19. APOBEC3G and HIV-1: strike and counterstrike.
Soros VB; Greene WC
Curr HIV/AIDS Rep; 2007 Feb; 4(1):3-9. PubMed ID: 17338854
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association.
Niewiadomska AM; Tian C; Tan L; Wang T; Sarkis PT; Yu XF
J Virol; 2007 Sep; 81(17):9577-83. PubMed ID: 17582006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
